Mission Pharmacal Co., Inc. acquires GlyDerm

On July 26, 2016, Mission Pharmacal Co., Inc. acquired GlyDerm, a consumer products company in New Jersey, United States, from Lautus Pharmaceuticals LLC.

Deal at a glance

AnnouncedJuly 26, 2016 TypeDivestiture TargetGlyDerm Buyer Mission Pharmacal Co., Inc. Seller Lautus Pharmaceuticals LLC SectorConsumer Products LocationNew Jersey, United States ValueNot disclosed

Target company

GlyDerm

New Jersey, United States

Consumer Productssector

-founded

Activestatus

View the company profile →

Buyer

Mission Pharmacal Co., Inc.

Company · 2 deals on record

1st transaction in consumer products
2nd transaction in United States

2deals, all time

1in this sector

2016latest

Seller

Lautus Pharmaceuticals LLC

Company · 1 deal on record

1investments

1in this sector

1exits

Members only

Contact details at the buyers and sellers

The full deal history of every party

Co-investors and the other advisors on this deal

Deal value and revenue or EBITDA multiples

Related deals

Thorne HealthTech, Inc.Same sector and country · Aug 2026

The Center Brands LLCSame sector and country · Jul 2026

Salt & StoneSame sector and country · Mar 2026

Questions about this deal

Who acquired GlyDerm?Mission Pharmacal Co., Inc. acquired GlyDerm on July 26, 2016.

Who sold GlyDerm?Lautus Pharmaceuticals LLC was the seller.

What type of deal was it?It was a divestiture in the consumer products sector in 2016.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.

Try it free

Data updated daily on AcquityData (Acquity Data).